July 3, 2023

The ASX is currently up 0.39 per cent, with the SPI futures pointing to a rise of 33 points. The best-performing sector is Materials, up 1.12 per cent, while the worst-performing sector is Information Technology, down 1.3 per cent. Turning over to company news, Pilbara Minerals is the best-performing large cap, trading 4.29 per cent

Lumos Diagnostics (ASX:LDX) has received FDA clearance for its FebriDx product, which can rapidly differentiate viral from bacterial infections at point of care. Doug Ward, CEO commented, “With this clearance in hand, we anticipate securing our first commercial orders in the US before the end of calendar year 2023.” Shares are trading 336.36 per cent

Oil prices remained relatively stable as the second half of the year began, as traders closely monitored factors affecting demand and the complex supply situation. Brent crude, the global benchmark, maintained its position above $75 per barrel, despite experiencing four consecutive quarterly losses, marking its longest downward trend in over 30 years. In 2021, oil

The US jobs data for June this Friday will give markets a good idea of the unusual first-half resilience of the American economy and labour market in the face of the spate of rate rises from the Federal Reserve. Despite numerous predictions, the US economy has not slumped like so many “gloomsters” had been predicting.

Stocks rose Friday and technology names continued their staggering run to cap off a strong start to the year, and the best first half for the Nasdaq Composite since 1983. The Dow Jones Industrial Average gained 285.18 points, or 0.84 per cent, to close at 34,407.60. The S&P 500 climbed 1.23 per cent to end